Legislators
Bills
Statements
Lobbying
Travel
Searching...- Bills
- H.RES.1125
H.RES.1125: Expressing support for prioritizing racial and ethnic diversity in clinical trials for therapies, diagnostics, and vaccines for COVID-19.
About This Bill
- This bill was introduced in the 116th Congress
- This bill is primarily about health
- Introduced Sept. 18, 2020
- Latest Major Action Sept. 18, 2020
Bill Sponsor
Bill Cosponsors
22 (All Democrats)
Bill Version
- Introduced in House - Sept. 18, 2020
Bill Summary
This resolution expresses the sense of the House of Representatives that federal agencies should take appropriate actions to (1) ensure meaningful engagement of communities of color in the conduct of COVID-19 (i.e., coronavirus disease 2019) research and participation in clinical trials, and (2) improve equitable access to safe and effective vaccines.
(Source: Library of Congress)
Bill Actions
| Date | Description |
|---|---|
| Sept. 18, 2020 |
Referred to the House Committee on Energy and Commerce.
|
| Sept. 18, 2020 |
Introduced in the House by Eliot L. Engel (D-N.Y.) |